Femtosecond not always appropriate

Article

Although femtosecond lasers offer a strong alternative to microkeratomes, they are not suitable for every situation, according to Theo Seiler, MD.

Although femtosecond lasers offer a strong alternative to microkeratomes, they are not suitable for every situation, according to Theo Seiler, MD speaking at the German Ophthalmic Surgeons Meeting held in Nuremberg, Germany in May.

Dr Seiler offered this argument following a presentation by Thomas Neuhann, MD, who argued that femtosecond lasers are able to produce flaps of homogenous thickness and allow more precise flap placement, making them the favourable choice in his opinion.

Dr Seiler, however, discussed a number of studies that suggest that flap creation does not have a significant effect on visual outcomes. He also argued that the frequency of transient light sensitivity, although improved, is still a drawback.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.